Literature DB >> 25874404

[Diagnosis and therapy of particle disease in total hip arthroplasty].

M Müller1, G Wassilew1, C Perka1.   

Abstract

Particle disease is caused by periarticular accumulation of attrition particles and the inflammatory reaction of the body's tissue. This process may result in osteolysis or soft tissue transformation which presents itself symptomless in the beginning and can proceed to aseptic implant loosening, fracture, implant breaking as a result of the inappropriate osseous support and to algetic and destructive soft tissue reactions as well. Attrition particles originate from tribological pairing, and the extent of the attrition or the particle concentration depend on different factors as there are the tribological pairing's material, the head size, the patient's level of activity, and the implant position. Attrition particles can also be found in the range of any modular connection. Particle disease and its resulting morphological alterations of the tribological pairing is one of the most frequent reasons for re-operation in hip endoprosthetics. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25874404     DOI: 10.1055/s-0035-1545827

Source DB:  PubMed          Journal:  Z Orthop Unfall        ISSN: 1864-6697            Impact factor:   0.923


  2 in total

1.  The impact of polyethylene abrasion on the occurrence of periprosthetic proximal femoral fractures in patients with total hip arthroplasty.

Authors:  Dirk Zajonz; Nora Lang; Cathleen Pönick; Melanie Edel; Robert Möbius; Harald Busse; Christoph Josten; Andreas Roth; Johannes K M Fakler
Journal:  Eur J Trauma Emerg Surg       Date:  2019-09-13       Impact factor: 3.693

2.  Femoral Stress Changes after Total Hip Arthroplasty with the Ribbed Prosthesis: A Finite Element Analysis.

Authors:  Changqi Luo; Xiang-Dong Wu; Yifei Wan; Junyi Liao; Qiang Cheng; Mian Tian; Zhibiao Bai; Wei Huang
Journal:  Biomed Res Int       Date:  2020-03-23       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.